Oncotarget is a peer-reviewed journal that deals with oncology- the scientific study of diagnosis, prevention, and treatment of cancer. This journal has a goal of providing worldwide information about cancer for free. For this reason, the journal has free access to everyone. One of the chief editors of Oncotarget is Professor Mikhail Blagosklonny. He is a specialist when it comes to Oncology and related fields. Mikhail serves as a full professor at Roswell Park Cancer Institute in Buffalo, New York, where he has been involved in uncountable research programs about cancer and its therapies. To add on to this, he has also published a lot of research papers on the online platform, Oncotarget, about Oncology. This Cancer specialized has pushed for the usage of Rapamycin to increase the lifespan of human beings. Visit Research Gate to keep up to date with Mikhail’s latest work.
Mikhail believes that this drug is one of the best medicines that we’ve ever had because of the following reasons;
- It treats cancer
The drug has antiproliferative properties that are key players in the treatment of cancer. Research has proved that the right dosage of Rapamycin induces an immune response towards the tumors. Other than that, it also enhances tumor regression hence putting this drug on the frontline in the fight against cancer.
- It is immunosuppressant
When there is an organ transplant, the human body may normally reject the graft. In this case, transplantation cannot occur unless an anti-rejection drug is administered. These drugs are known as immunosuppressive drugs or calcineurin inhibitors. The problem with this drugs is that they are toxic to the kidney. However, Rapamycin records the least toxicity to the kidney. Read more on Impact Journals.
- It treats Hemolytic-uremic Syndrome
This disease occurs as a result of the combination of low platelet counts, anemia, and kidney failure. Patients opt to have kidney transplantation as a corrective measure for the disease. This, however, can lead to the transplanted kidney contracting the disease. Rapamycin reduces the chances of this contraction because of its low levels of toxicity towards the kidney.
These are just but a few of the reasons of why Mikhail advocates for Rapamycin. Apart from being a professor, Mikhail Blagosklonny is also a philanthropist who works hard to ensure that people have the best treatments for the least cost possible. Having an interest in the study of aging and cancer, he intends to find out the reason behind cancer being more prevalent in older people than in younger people. He goes on with his research hoping to achieve more and make a huge impact in Oncology. Mikhail Blagosklonny is not only a lecturer to his students; he has acted as a role model and inspiration to a lot of students as well as his peers. Many young scientists look up to him and are inspired by his tremendous successes in research. Mikhail has been recognized by the world of science because of the exciting topics he chose to research concerning cancer. His dream is to one day see a world that has standard techniques that treat cancer less painfully.